Ground-breaking scan may identify liver disease

November 26, 2013, University of Birmingham

A ground-breaking scan that can identify and help to treat liver disease, could make painful and invasive liver biopsies a thing of the past, thanks to a trial being led by the University of Birmingham.

Nearly 15 million people in the UK are affected by liver disease and this number is increasing. Most suffer from which is linked to obesity, diabetes and alcohol excess and in severe cases can cause cancer or death. The Chief Medical Officer for England, Dame Sally Davies, identified it as a priority for the NHS in her report on the state of the nation's health and called for urgent action to reverse the trend.

Patients who are suspected of having liver disease will usually be sent for an invasive biopsy to assess the level of damage. But, as well as being painful and uncomfortable, biopsies have some drawbacks, including the fact that they cannot be used over and over again on the same patient. The new scan, called LiverMultiscan, could be used numerous times which means doctors will find it easier to monitor the progress of the disease and adapt the treatment plan accordingly for the individual.

The trial is a collaboration between clinicians and scientists at the NIHR Liver Biomedical Research Unit at the University of Birmingham, the University of Edinburgh and medical imaging company Perspectum Diagnostics. It is supported by a grant of £1.2 million from the UK's innovation agency, the Technology Strategy Board.

Until now, non-invasive tests such as blood tests and routine scans have been limited in detecting , especially in the early stages where patients have the most to gain from treatment. The only current accurate way to diagnose liver disease is through a where a needle is put into the liver and a sample of tissue is taken. This is uncomfortable and carries a small risk of serious complications.

Alex Morris, 40, from Birmingham, has had two liver biopsies. The first one, at Birmingham's Queen Elizabeth Hospital in 2012, confirmed she was suffering from liver disease.

She said that the ground breaking scan would be far preferable to a biopsy.

"Biopsies are not nice, not at all. They are a necessary evil, to diagnose you and to monitor whether you are getting any worse, but they are not nice," she said.

"The staff, the nurses, the doctors, they were all fantastic and explained what was happening the whole time. I was nervous and scared going in, and they really do everything they can to put you at your ease. But the anxiety of knowing you may be about to be diagnosed with a disease, together with undergoing a procedure does make it scary.

"If it comes down to a scan or a biopsy, and you can get the same result from both, I would choose a scan every time."

Miss Morris said that her biopsies took her about a week each to physically recover from.

If successful, LiverMultiscanTM, which uses a new type of MRI (magnetic resonance imaging) technology could be used throughout the UK to diagnose patients with liver disease without resorting to biopsies and could be available to patients in the NHS within three years.

Over the next two years the clinical study being undertaken will further assess LiverMultiscanTM and will also use the technology to monitor a group of patients with primary sclerosing cholangitis to see how well changes in the liver can be tracked over time.

Dr Peter Eddowes, Clinical Research Fellow in Hepatology at the University of Birmingham said:

"Liver disease often has no symptoms and people can go for years not knowing their liver is damaged. Current non-invasive tests lack the sensitivity to reliably pick up early "

Dr Gideon Hirschfield, the chief investigator on the study said:

"We are pleased to run this study in Birmingham alongside our partners in Edinburgh and Oxford. We hope LiverMultiscanTM will improve the care of liver patients and enable us to provide a quicker, cheaper and most importantly, safer diagnosis."

Explore further: Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable

Related Stories

Fast, painless alternative to liver biopsies for hepatitis patients proves accurate and reliable

October 31, 2013
A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national multi-center study including Henry Ford Hospital.

Research tackles liver transplant failure

November 7, 2013
The re-infection of transplanted livers with hepatitis C virus (HCV) – which can irreparably damage the new organ - could be halted by administering a drug which blocks the virus entering the liver, research from the University ...

Imaging technique detects pediatric liver disease without need for needle biopsy

September 20, 2013
A new, non-invasive imaging technique, magnetic resonance elastography (MRE), can now help physicians accurately detect fibrosis (scarring) in children with chronic liver disease – a growing problem due in part to increasing ...

New non-invasive test may detect liver disease earlier

July 3, 2013
Researchers from the National Institute for Health Research (NIHR) Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham will be showing ...

Bowel cancer patients miss out on life-saving liver surgery

October 29, 2013
Bowel cancer patients whose disease has spread to the liver are not being referred to specialists for potentially life-saving surgery, according to research published in the British Journal of Surgery.

Weight loss surgery alters fatty liver disease genes

August 6, 2013
Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also ...

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.